Medical Devices Startups

Rapid-myco Technologies develops bacteriophage-based diagnostic tests for detecting mycobacterial infections in humans and livestock, with rapid turnaround times. The company offers tests for diseases including Johne's disease in livestock and tuberculosis in humans and animals.

1 investor

Rapid Novor develops protein sequencing software and methods for antibody analysis, combining bioinformatics and mass spectrometry technology. The company specializes in proteomics services for clients requiring high-throughput antibody sequencing.

1 investor

Rapid Nexus Nanotech Wound Solutions develops a regenerative medical device technology (Hemastyl) that aims to repair nerves, muscle, and vasculature to heal chronic non-healing wounds and prevent amputations. It targets patients with diabetes, trauma, and peripheral vascular disease in the peripheral neuropathy and diabetic foot ulcer markets.

1 investor

Rappta Therapeutics develops small molecule compounds that reactivate protein phosphatase 2A (PP2A) to treat cancer by restoring the enzyme's tumor suppressor function. The company targets the underlying mechanism of protein hyperphosphorylation that drives cancer progression.

1 investor

RasCal Therapeutics develops targeted cancer therapies aimed at previously "untargetable" mutations that drive some of the deadliest cancers, using novel mechanisms intended to work alongside conventional treatments, targeted therapies, and immunotherapies. The company is conducting human clinical trials of its lead anti-cancer compound.

1 investor

Raval is a manufacturer specializing in precision plastic injection molding for automotive applications, with a strong presence in emission control, battery, and pressure regulation systems for traditional and electric vehicles. The company serves major automotive OEMs and Tier 1 suppliers globally.

1 investor

RayBalance develops a proprietary, non-reformulation platform that treats the subcutaneous injection administration site as a delivery-performance variable to improve absorption predictability without altering a partner's drug product. It targets pharmaceutical companies, biosimilar manufacturers, and medical device companies working on follow-on/biosimilar differentiation, lifecycle strategy, and IV-to-SC transition.

1 investor

RAYDIAX develops image-guided therapy assistance solutions, specifically a CT imaging system called TACT designed for minimally invasive medical procedures. The company serves clinical users and patients across the global healthcare system.

1 investor

Rayence develops digital X-ray detectors for dental, medical, veterinary, and industrial applications using proprietary CMOS wafer design, TFT panel, and scintillator technology. The company exports medical device components globally and has been recognized for innovations including flexible intraoral sensors.

1 investor

RCE Technologies develops a wrist-worn wearable (Infrasensor) that uses infrared sensors and machine learning to detect signals associated with severe coronary artery occlusion, aiming for earlier heart attack detection. The technology targets clinical and acute care settings such as emergency departments and pre-hospital paramedic use.

1 investor

RD Biotech provides a compact, high-throughput automated diagnostic testing platform that processes up to 1,440 samples in 24 hours across reproductive health, respiratory infections, bloodborne diseases, and enteroviruses. The system is designed for clinical laboratories and diagnostic facilities seeking space-efficient batch processing with flexible sample loading.

1 investor

REACH operates a 24/7 communications center (Flight Guard) staffed by flight coordinators and aviation experts who coordinate patient transport via helicopter, fixed-wing aircraft, and ground ambulances for critically ill or injured patients. The service partners with public agencies, hospitals, and transport providers to ensure appropriate transport solutions during all conditions and resource constraints.

1 investor

Reacta Healthcare provides standardized meal products for oral food challenge testing, which is a clinical procedure used in allergy diagnosis and management.

1 investor

Reaction Biology provides drug discovery and development services for pharmaceutical companies, offering preclinical research platforms including biochemistry, in vivo efficacy testing, and patient-derived xenograft models.

1 investor

RealSeq Biosciences develops RNA fragmentomics technology for advanced diagnostics, enabling detection and analysis of RNA fragments to discover new biomarkers and provide deeper insights into disease. The company serves the healthcare and diagnostics industry by unlocking previously inaccessible biological information from RNA.

1 investor

Reapplix develops advanced wound care products and therapeutics for clinical use. The company serves healthcare systems and wound care providers in the medical device and regenerative medicine sector.

1 investor

Reaxing designs and sells fitness training equipment and systems that use patented sensory technology to enhance neuromuscular and proprioceptive training outcomes. The company serves fitness professionals, trainers, and gyms with modular functional training products and "all-in-one" training stations.

1 investor

Rebrain provides an AI-driven SaaS platform for planning patient-specific neuromodulation and neurosurgery, aiming to make treatment of neurological and neurodegenerative diseases faster and safer for doctors and patients. It is a spin-off of the University Hospital of Bordeaux and Inria, serving medical centers and neurosurgeons.

1 investor

Reccan is a medtech company focused on improving early diagnosis and prognosis for patients with pancreatic cancer through the development of biomarker-based diagnostic tools. The company leverages decades of clinical and translational research at Lund University Hospital to address limitations in existing tumor markers.

1 investor

Red Bag Solutions is a healthcare company that develops sterilization and infection control solutions, including SSM (Sterile Specimen Management) technology and equipment. The company serves healthcare facilities and institutions requiring quality assurance and technical support for medical sterilization processes.

1 investor

RedBrick AI provides an annotation platform for medical imaging that enables radiologists and AI developers to create training datasets for radiology AI applications. The platform combines advanced segmentation tools, collaborative workflows, and compliance features for building high-quality medical imaging datasets.

1 investor

RedDress develops autologous wound healing solutions, including its ActiGraft/ActiGraftPro product that uses a patient's own blood to create a blood-derived clot for treating chronic, non-healing wounds. It sells to healthcare providers and clinicians, with products eligible for Medicare reimbursement in the U.S.

1 investor

Redefine Surgery develops an AI-powered surgical navigation and robotics platform designed for orthopedic procedures, combining computer-vision guidance with compact robotic instruments to enable faster surgery with greater precision. The platform is built for surgeons seeking to improve efficiency and consistency while maintaining control over their procedures.

1 investor

Redicine develops a solution aimed at improving medication adherence and reducing medication errors for patients on chronic or intensive medication regimens. The company positions its product as a tool to address the risks of incorrect medication adherence, which it frames as a global patient safety issue.

1 investor